| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/21/2002 | CA2422376A1 Isoxazoles and their use as inhibitors of erk |
| 03/21/2002 | CA2422275A1 Compositions and methods for inhibition of hiv-1 infection |
| 03/21/2002 | CA2422060A1 Compositions comprising mixtures of human cytokines and methods of producing the same |
| 03/21/2002 | CA2422032A1 The diagnosis, prevention, amelioration and/or treatment of disturbed immune function induced by disturbed lipid metabolism |
| 03/21/2002 | CA2422002A1 Vaccine |
| 03/21/2002 | CA2421998A1 Vaccine against streptococcus pneumoniae |
| 03/21/2002 | CA2421994A1 The diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases |
| 03/21/2002 | CA2421952A1 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 03/21/2002 | CA2421935A1 An antimicrobial composition |
| 03/21/2002 | CA2421920A1 Use of arginine in the preparation of a medicament for the prevention and treatment of the side effects associated with the intravenous administration of pharmaceuticals |
| 03/21/2002 | CA2421279A1 2-amino-2-alkyl-3 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/21/2002 | CA2421234A1 Interferon-alpha induced gene |
| 03/21/2002 | CA2419244A1 System and method for optimizing drug therapy for the treatment of diseases |
| 03/21/2002 | CA2419224A1 Chemokine receptor binding heterocyclic compounds |
| 03/21/2002 | CA2419219A1 Chemokine receptor binding heterocyclic compounds |
| 03/21/2002 | CA2418720A1 Caspase inhibitors and uses thereof |
| 03/21/2002 | CA2416563A1 Pharmaceutical composition having specific water activity |
| 03/20/2002 | EP1188831A2 Target of RNAIII activating protein (TRAP) |
| 03/20/2002 | EP1188825A1 T cell receptor transfer into a candidate effector cell or a precursor thereof |
| 03/20/2002 | EP1188766A1 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 03/20/2002 | EP1188754A1 Substituted pyrazole compounds |
| 03/20/2002 | EP1188750A1 Process for the preparation of 2,5-diamino-4,6-dihalogenopyrimidinen |
| 03/20/2002 | EP1188446A1 Proteinaceous vectors for molecule delivery to CD11b expressing cells |
| 03/20/2002 | EP1188438A1 Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production |
| 03/20/2002 | EP1187931A1 49 human secreted proteins |
| 03/20/2002 | EP1187916A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 03/20/2002 | EP1187913A1 Screening method for peptides |
| 03/20/2002 | EP1187908A1 42 human secreted proteins |
| 03/20/2002 | EP1187852A1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS |
| 03/20/2002 | EP1187847A1 Streptogramin derivatives, preparation and compositions containing them |
| 03/20/2002 | EP1187843A1 Angiogenic proteins and uses thereof |
| 03/20/2002 | EP1187842A1 Human tumor necrosis factor receptor tr10 |
| 03/20/2002 | EP1187837A1 Thiazepine inhibitors of hiv-1 integrase |
| 03/20/2002 | EP1187835A1 Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substitutes causing optical activity and a process for preparing thereof |
| 03/20/2002 | EP1187828A1 Quinoline derivatives as antibacterials |
| 03/20/2002 | EP1187827A1 Antiviral agents |
| 03/20/2002 | EP1187817A1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 03/20/2002 | EP1187813A1 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 03/20/2002 | EP1187631A1 Prevention of type 1 diabetes and other non-polio enterovirus diseases |
| 03/20/2002 | EP1187629A2 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 03/20/2002 | EP1187624A1 Conformationally constrained backbone cyclized interleukin-6 antagonists |
| 03/20/2002 | EP1187622A1 Method of sterilizing |
| 03/20/2002 | EP1187613A1 Amide substituted imidazoquinolines |
| 03/20/2002 | EP1187608A1 Indole compounds |
| 03/20/2002 | EP1187607A1 Indole compounds |
| 03/20/2002 | EP1187592A2 Alpha v integrin receptor antagonists |
| 03/20/2002 | EP1156040A4 2,4-dioxo-5-arylidenimino-1,3-pyrimidines |
| 03/20/2002 | EP0837860B1 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO(3,4-c]-1,2,4-TRIAZOLO(4,3-ALPHA]PYRIDINES |
| 03/20/2002 | EP0642351B1 New pharmaceutical uses of krill enzymes |
| 03/20/2002 | EP0625043B1 Recombinant multivalent m protein vaccine |
| 03/20/2002 | EP0591385B1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 03/20/2002 | CN1341116A Crystal modification D of 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-[4.3.0] nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid |
| 03/20/2002 | CN1341099A 2-aminopyridines containing fused ring substituents |
| 03/20/2002 | CN1341029A Use of an OmpA enterobacteriumprotein associated with the ELAGIGILTV peptide for treating melanomas |
| 03/20/2002 | CN1340359A Two-element active antibody preparation and its preparing process |
| 03/20/2002 | CN1081055C Medicinal liquor for treating and fistula |
| 03/20/2002 | CN1081037C Azithromycin suppository and ointment |
| 03/19/2002 | USRE37596 Hybridoma cell line which produces the monoclonal antibody bw sclc-1 having the deposit number ecacc no. 90022110. |
| 03/19/2002 | US6359182 C-nitroso compounds and use thereof |
| 03/19/2002 | US6359167 Stable NO-delivering compounds |
| 03/19/2002 | US6359137 Antibiotic |
| 03/19/2002 | US6358985 Inhibitors of prenyl-protein transferase |
| 03/19/2002 | US6358971 Anti-viral compounds |
| 03/19/2002 | US6358970 Integrin receptor antagonists |
| 03/19/2002 | US6358969 3-desmethylrapamycin or derivatives thereof, processes for their preparation and their use as antifungal agents and immunosuppressants |
| 03/19/2002 | US6358963 For therapy of viral infections |
| 03/19/2002 | US6358956 Inhibitors of prenyl-protein transferase |
| 03/19/2002 | US6358953 Administering pterin metal complex as anticarcinogenic agents and viricides |
| 03/19/2002 | US6358952 Combination of benzoquinazoline antifolates and protecting agents |
| 03/19/2002 | US6358945 Compounds useful as anti-inflammatory agents |
| 03/19/2002 | US6358942 Microbiocides and bactericides for treating grampositive, bacteroides, clostridium, mycobacterium, staphylococcus and streptococcus infections |
| 03/19/2002 | US6358934 Administering viricide to treat human t-cell leukemia/lymphoma and hepatitis virus infections; acquired immunodeficiency syndrome (aids) treatment |
| 03/19/2002 | US6358919 Polymer compounds comprising glycosphingosine |
| 03/19/2002 | US6358727 Nucleotide sequences coding binding protein for use in treatment and prevention of infections |
| 03/19/2002 | US6358704 M protein |
| 03/19/2002 | US6358695 Determining compounds that activate or inhibit a g-protein receptor by exposing cells expressing the polypeptide on the surface with a test compound to allow binding and detect a signal in response to binding of agent to the polypeptide |
| 03/19/2002 | US6358524 Target cell-specific non-viral vectors for inserting genes into cells, pharmaceutical compositions comprising such vectors and their use |
| 03/19/2002 | US6358512 Feline infectious peritonitis vaccine |
| 03/19/2002 | US6357163 Use of nucleic acid analogues in diagnostics and analytical procedures |
| 03/19/2002 | CA2250036C Antibiotic cocktail and method of use |
| 03/19/2002 | CA2187110C Benzamide derivative, compositions containing said derivative and use thereof |
| 03/19/2002 | CA2157508C Ionene polymers as microbicides |
| 03/19/2002 | CA2151588C Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone |
| 03/19/2002 | CA2055912C Novel erythromycin derivatives, their preparation process, the new intermediated obtained and their application as drugs |
| 03/19/2002 | CA2047347C Thioalkylthio cephalosporins derivatives |
| 03/19/2002 | CA2032303C Inhibitors of retroviral proteases |
| 03/19/2002 | CA1341348C Human tumor necrosis factor |
| 03/15/2002 | CA2357155A1 Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
| 03/14/2002 | WO2002020822A2 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 03/14/2002 | WO2002020816A1 Novel compound f-15949 |
| 03/14/2002 | WO2002020814A1 Self-rearranging dna vectors |
| 03/14/2002 | WO2002020804A1 Rat cathepsin, dipeptidyl peptidase i (dppi): crystal structure, inhibitors and its uses |
| 03/14/2002 | WO2002020773A2 Chimeric antisense oligonucleotides of arabinofuranose analogues and deoxyribose nucleotides |
| 03/14/2002 | WO2002020769A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | WO2002020767A2 G-csf analog compositions and methods |
| 03/14/2002 | WO2002020766A2 G-csf analog compositions and methods |
| 03/14/2002 | WO2002020762A2 Tnf receptor-like molecules and uses thereof |
| 03/14/2002 | WO2002020736A2 Proteases |
| 03/14/2002 | WO2002020724A2 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 03/14/2002 | WO2002020723A2 Compositions and methods for targeting peptides in humans in vivo |